Due to rising prescription costs and increasing use, have made this change necessary to protect the long-term sustainability of the healthcare benefits for all beneficiaries.
The following prescription medications are no longer reimbursed by Marram.
- Wegovy - Semaglutide
- Saxenda - Liraglutide
- Contrave - Naltrexone/ Bupropion
- Duromine - Phentermine
- Xenical - Orlistat
- Mounjaro - Tirzepatide
- Ozempic - Semaglutide
This change applies to all receipts dated 1 March 2026 or later.
Thank you for your understanding.